BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31624984)

  • 1. Cinnamaldehyde: a compound with antimicrobial and synergistic activity against ESBL-producing quinolone-resistant pathogenic Enterobacteriaceae.
    Dhara L; Tripathi A
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):65-73. PubMed ID: 31624984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of eugenol in combination with cefotaxime and ciprofloxacin to combat ESBL-producing quinolone-resistant pathogenic Enterobacteriaceae.
    Dhara L; Tripathi A
    J Appl Microbiol; 2020 Dec; 129(6):1566-1576. PubMed ID: 32502298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of genetic factors towards cefotaxime and ciprofloxacin resistance development among Extended spectrum beta-lactamase producing-Quinolone resistant pathogenic Enterobacteriaceae.
    Dhara L; Tripathi A
    Gene; 2024 Jan; 893():147921. PubMed ID: 37884102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sub-acute toxicological and behavioural effects of two candidate therapeutics, cinnamaldehyde and eugenol, for treatment of ESBL producing-quinolone resistant pathogenic Enterobacteriaceae.
    Dhara L; Tripathi A
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):977-988. PubMed ID: 32027395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
    Aris P; Boroumand MA; Rahbar M; Douraghi M
    Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of acquired quinolone-resistance genes among Enterobacteriaceae from Saudi Arabia with CTX-M-15 β-lactamase.
    Shibl AM; Al-Agamy MH; Khubnani H; Senok AC; Tawfik AF; Livermore DM
    Diagn Microbiol Infect Dis; 2012 Aug; 73(4):350-3. PubMed ID: 22633335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of the plasmid-mediated quinolone resistance determinant qnrA in multidrug-resistant Enterobacteriaceae from blood cultures in Liverpool, UK.
    Corkill JE; Anson JJ; Hart CA
    J Antimicrob Chemother; 2005 Dec; 56(6):1115-7. PubMed ID: 16260446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of extended spectrum β-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis in Okinawa prefecture, Japan.
    Nakama R; Shingaki A; Miyazato H; Higa R; Nagamoto C; Hamamoto K; Ueda S; Hachiman T; Touma Y; Miyagi K; Kawahara R; Toyosato T; Hirai I
    J Infect Chemother; 2016 May; 22(5):281-6. PubMed ID: 26898665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study.
    Reuland EA; Sonder GJ; Stolte I; Al Naiemi N; Koek A; Linde GB; van de Laar TJ; Vandenbroucke-Grauls CM; van Dam AP
    Clin Microbiol Infect; 2016 Aug; 22(8):731.e1-7. PubMed ID: 27223840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia.
    Vlieghe ER; Huang TD; Phe T; Bogaerts P; Berhin C; De Smet B; Peetermans WE; Jacobs JA; Glupczynski Y
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1223-9. PubMed ID: 25717021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of bactericidal and synergistic activity of quercetin with meropenem among pathogenic carbapenem resistant Escherichia coli and Klebsiella pneumoniae.
    Pal A; Tripathi A
    Microb Pathog; 2020 Jun; 143():104120. PubMed ID: 32169488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of ceftazidime-avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance.
    López-Hernández I; Alonso N; Fernández-Martínez M; Zamorano L; Rivera A; Oliver A; Conejo MC; Martínez-Martínez L; Navarro F; Pascual A
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):499-504. PubMed ID: 27887765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-spectrum beta-lactamases and the permeability barrier.
    Martínez-Martínez L
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():82-9. PubMed ID: 18154531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
    Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
    J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Cefotaxime-Resistant Escherichia coli Isolates from Healthy Cattle and Sheep in Northern Spain: Phenotypic and Genome-Based Characterization of Antimicrobial Susceptibility.
    Tello M; Ocejo M; Oporto B; Hurtado A
    Appl Environ Microbiol; 2020 Jul; 86(15):. PubMed ID: 32471914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of
    Benameur Q; Gervasi T; Pellizzeri V; Pľuchtová M; Tali-Maama H; Assaous F; Guettou B; Rahal K; Gruľová D; Dugo G; Marino A; Ben-Mahdi MH
    Nat Prod Res; 2019 Sep; 33(18):2647-2654. PubMed ID: 29726697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of Enterobacteriaceae co-producing CTX-M-15, ArmA and PMQR in Poland.
    Piekarska K; Zacharczuk K; Wołkowicz T; Wolaniuk N; Rzeczkowska M; Gierczyński R
    Adv Clin Exp Med; 2019 Feb; 28(2):249-254. PubMed ID: 30499638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
    Mohanty S; Gaind R; Ranjan R; Deb M
    J Infect Dev Ctries; 2009 Nov; 4(1):24-9. PubMed ID: 20130375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates.
    Al-Zarouni M; Senok A; Rashid F; Al-Jesmi SM; Panigrahi D
    Med Princ Pract; 2008; 17(1):32-6. PubMed ID: 18059098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.